Current Assets تغيير تاريخ
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Avrobio USD 109.17M 19.67M 2023-09
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Capricor Therapeutics USD 29.53M 9.4M 2023-09
Daiichi Sankyo JPY 1.52T 15.17B 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Insmed USD 929.06M 2.49M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Lumos Pharma USD 47.45M 8.54M 2023-09
Moderna USD 10.32B 474M 2023-12
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Novavax USD 1.01B 120.79M 2023-09
Pfizer USD 74.01B 665M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09



Sarepta Therapeutics أصول متداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2024.